|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| OPERATING EXPENSES | ||||
| Research and development expenses | ||||
| General and administrative expenses | ||||
| Total operating expenses | ||||
| LOSS FROM OPERATIONS | ||||
| LOSS, BEFORE INCOME TAX | ||||
| NET LOSS | ||||
| Net loss per share attributable to common shareholders, basic | ||||
| Net loss per share attributable to common shareholders, diluted | ||||
| Weighted average common shares outstanding used in computing net loss per share attributable to common shareholders, basic | ||||
| Weighted average common shares outstanding used in computing net loss per share attributable to common shareholders, diluted | ||||
Loading...
